Cogent Biosciences
COGT
#6495
Rank
A$0.89 B
Marketcap
$7.89
Share price
-10.51%
Change (1 day)
-24.68%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of December 2024 : A$0.47 Billion

According to Cogent Biosciences's latest financial reports the company has A$0.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.46 B18.34%
2023-12-31A$0.39 B2.36%
2022-12-31A$0.38 B25.74%
2021-12-31A$0.30 B-3.79%
2020-12-31A$0.31 B489.26%
2019-12-31A$53.45 M-52.09%
2018-12-31A$0.11 B112.64%
2017-12-31A$52.46 M-44.8%
2016-12-31A$95.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$27.1 M-94.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.71 B 50.46%๐Ÿ‡บ๐Ÿ‡ธ USA